Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

A response to someone on stocktwits who thinks I m

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154140
(Total Views: 975)
Posted On: 02/17/2022 8:33:52 AM
Posted By: ohm20
A response to someone on stocktwits who thinks I must be wrong and Cytodyn must be right on the most basic MOA of leronlimab. With Cytodyn's misunderstanding of their own MOA is it any wonder the FDA would be confused.

Quote:
ohm, I beg to differ here. this video: at minute 2:37 says "... conversely, PRO 140 is designed both to block HIV and PERMIT normal chemokine binding."
https://www.youtube.com/watch?v=sCMwoVYeRA0



Quote:
That was based on the original inventors premise and it's wrong. When leronlimab was originally invented a lot less was known about the CCR receptors. I think they based that on he fact that there was still immune activity so they thought the chemokines were not being blocked, not realizing that immune activity would still occur through the other receptors. I was the first one to point out that they were wrong and Dr. Recknor told me they were looking into the MOA and biomarkers.

My conclusion that it was wrong is very simple logic. If leronlimab allowed chemokine binding and regular immune activation it would have no activity against overinflammation and autoimmunity. The fact that both the chemokines and leronlimab bind to the n terminus and the chemokines cannot attach when leronlimab is already there is a straightforward proposition.

My thesis for how it's actually working I believe is the correct one. We know that all of the CCR receptors increase when an immune or injurious challenge is presented. CCR5 is by far the most prolific CCR receptor and is the main CCR mechanism in the immune system. The other receptors are mainly backups to it.

You have elevated CCR receptors, elevated chemokine levels and an overinflammatory/autoimmune response mainly due to the CCR5 receptor but also a lower level from the other CCR receptors. The other CCR receptors response in a normal state would be very low. In the elevated state of high immune response those other receptors would equate to a normal immune response due to increased expression. But then you have the CCR5 receptor on top of it with a massive immune response causing disarray. Effectively block the CCR5 receptor and only the normal level of immune response from the other receptors is left. In other words immune homeostasis.



(14)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us